UKBizDB.co.uk

NEPHRO-UROLOGY CLINICAL TRIALS LTD.

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Nephro-urology Clinical Trials Ltd.. The company was founded 22 years ago and was given the registration number 04558123. The firm's registered office is in LONDON. You can find them at Queen Anne Street Medical Centre, 18-22 Queen Anne Street, London, . This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name:NEPHRO-UROLOGY CLINICAL TRIALS LTD.
Company Number:04558123
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:09 October 2002
End of financial year:31 March 2023
Jurisdiction:England - Wales
Industry Codes:
  • 72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address:Queen Anne Street Medical Centre, 18-22 Queen Anne Street, London, W1G 8HU
Country Origin:
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
6 The Postern, Barbican, London, EC2Y 8BJ

Secretary09 October 2002Active
6 The Postern, Barbican, London, EC2Y 8BJ

Director09 October 2002Active
Burlington House, 40 Burlington Rise, East Barnet, EN4 8NN

Nominee Secretary09 October 2002Active
10 Saint Leonards Road, Surbiton, KT6 4DE

Director09 October 2002Active
Burlington House, 40 Burlington Rise, East Barnet, EN4 8NN

Nominee Director09 October 2002Active

People with Significant Control

B R L Group Limited
Notified on:18 December 2018
Status:Active
Country of residence:England
Address:1 Tower House, Tower Centre, Hoddesdon, England, EN11 8UR
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent
Dr. Brian Robert Leaker
Notified on:06 April 2016
Status:Active
Date of birth:September 1954
Nationality:British
Country of residence:England
Address:6, The Postern, Barbican, London, England, EC2Y 8BJ
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (1 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (0 months remaining)

Copyright © 2024. All rights reserved.